Groupama Asset Managment Bio N Tech Se Transaction History
Groupama Asset Managment
- $6.04 Trillion
- Q2 2025
A detailed history of Groupama Asset Managment transactions in Bio N Tech Se stock. As of the latest transaction made, Groupama Asset Managment holds 223,225 shares of BNTX stock, worth $23.9 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
223,225
Previous 196,544
13.58%
Holding current value
$23.9 Million
Previous $18.7 Billion
27.65%
% of portfolio
0.39%
Previous 0.37%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
316Shares Held
40.8MCall Options Held
1.37MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$859 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$452 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$428 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$385 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$203 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...